title: Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors.
authors.forename: E
authors.initials: E
authors.lastname: Brissot
authors.forename: P
authors.initials: P
authors.lastname: Chevallier
authors.forename: T
authors.initials: T
authors.lastname: Guillaume
authors.forename: J
authors.initials: J
authors.lastname: Delaunay
authors.forename: S
authors.initials: S
authors.lastname: Ayari
authors.forename: V
authors.initials: V
authors.lastname: Dubruille
authors.forename: S
authors.initials: S
authors.lastname: Le Gouill
authors.forename: B
authors.initials: B
authors.lastname: Mahe
authors.forename: T
authors.initials: T
authors.lastname: Gastinne
authors.forename: N
authors.initials: N
authors.lastname: Blin
authors.forename: B
authors.initials: B
authors.lastname: Saulquin
authors.forename: P
authors.initials: P
authors.lastname: Moreau
authors.forename: J-L
authors.initials: JL
authors.lastname: Harousseau
authors.forename: M
authors.initials: M
authors.lastname: Mohty
mesh_terms: D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012189:Retrospective Studies; D016019:Survival Analysis; D019172:Transplantation Conditioning / Q000379:methods*; D055815:Young Adult
chemical_list: D000961:Antilymphocyte Serum; D016572:Cyclosporine; D009173:Mycophenolic Acid